• Issue

    Clinical Genetics: Volume 99, Issue 3

    333-489
    March 2021

ISSUE INFORMATION

Free Access

Issue Information

  • Page: 333
  • First Published: 08 February 2021

ORIGINAL ARTICLES

Full Access

Deficiency of acyl-CoA synthetase 5 is associated with a severe and treatable failure to thrive of neonatal onset

  • Pages: 376-383
  • First Published: 15 November 2020
Deficiency of acyl-CoA synthetase 5 is associated with a severe and treatable failure to thrive of neonatal onset

ACSL5 biallelic loss-of-function variants lead to severe failure to thrive, but treatable with dietary restriction of long-chain triglycerides.

SHORT REPORTS

Full Access

Biallelic mutations of CFAP58 are associated with multiple morphological abnormalities of the sperm flagella

  • Pages: 443-448
  • First Published: 13 December 2020
Biallelic mutations of CFAP58 are associated with multiple morphological abnormalities of the sperm flagella

The multiple morphological abnormalities of the sperm flagella (MMAF) is one of the most severe types of teratozoospermia. In this study, we conducted whole-exome sequencing on 55 MMAF patients to identify the genetic etiology. Biallelic mutations of CFAP58 were identified from two patients. The variants are rare and disease causing, and CFAP58 was absent in the patients' sperm. Moreover, the TEM results showed the absence of central pairs and disruption of the DMTs. Intracytoplasmic sperm injection (ICSI) was carried out for couple of F037/II:1, his wife became pregnant and gave birth to a baby. This study further demonstrates that CFAP58 is a pathogenic gene of MMAF.

Full Access

IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?

  • Pages: 462-474
  • First Published: 28 December 2020
IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?

IQSEC2 mutations are associated to a neurodevelopment disorder (OMIM #300522) which shares many characteristics with Rett syndrome. With the aim of establishing a genotype-phenotype correlation, we collected molecular and clinical data of 16 patients harbouring IQSEC2 point mutations (15 previously unreported) and of 5 novel patients carrying CNVs encompassing IQSEC2, some of them being familial cases. Our data support the idea that position, type of variant and gender are crucial to determine the phenotype associated to IQSEC2 mutations.

LETTERS TO THE EDITOR